Related Experiment Video
Updated: Jul 13, 2025

07:29
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
20.0K
Paediatric cornea crosslinking current strategies: A review
Pawan Prasher1, Ashok Sharma2, Rajan Sharma2
1Department of Ophthalmology, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India.
Advances in Ophthalmology Practice and Research
|October 17, 2023
Summary
Corneal collagen cross-linking halts keratoconus progression in children. The Dresden protocol is effective, but accelerated or transepithelial methods offer alternatives with varying outcomes.
Area of Science:
- Ophthalmology
- Corneal diseases
Background:
- Keratoconus affects 1 in 2000 people, with higher incidence in Southeast Asians.
- Children present earlier with more severe keratoconus, and eye rubbing is a risk factor.
- Progression in children is rapid, making visual rehabilitation challenging and often requiring early keratoplasty.
Purpose of the Study:
- To evaluate the efficacy of corneal collagen cross-linking (CXL) in halting keratoconus progression in children.
- To compare different CXL protocols, including the Dresden protocol, accelerated CXL, and transepithelial CXL.
Main Methods:
- The Dresden protocol involves central corneal de-epithelialization, riboflavin saturation, and UV-A exposure.
- Accelerated CXL reduces operative time, while transepithelial CXL avoids de-epithelialization.
- Treatment should be preceded by managing vernal keratoconjunctivitis.
Main Results:
- Corneal collagen cross-linking is safe and effective in stopping keratoconus progression in children.
- The Dresden protocol is highly successful but has drawbacks like long operating time and pain.
- Accelerated CXL is equally effective in some studies, and transepithelial CXL is safer but less effective.
Conclusions:
- The Dresden protocol is recommended for halting pediatric keratoconus progression.
- Accelerated CXL is a viable faster alternative.
- Transepithelial CXL offers safety benefits but reduced efficacy for stabilization.
Related Concept Videos
Angle Closure Glaucoma: Treatment
536
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
536
Open Angle Glaucoma: Treatment
459
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
459

